Robert E Burke
Robert E Burke
Geverifieerd e-mailadres voor
Geciteerd door
Geciteerd door
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
Validity and reliability of a rating scale for the primary torsion dystonias
RE Burke, S Fahn, CD Marsden, SB Bressman, C Moskowitz, J Friedman
Neurology 35 (1), 73-73, 1985
Clinical progression in Parkinson disease and the neurobiology of axons
HC Cheng, CM Ulane, RE Burke
Annals of neurology 67 (6), 715-725, 2010
Resistance of α-synuclein null mice to the parkinsonian neurotoxin MPTP
W Dauer, N Kholodilov, M Vila, AC Trillat, R Goodchild, KE Larsen, ...
Proceedings of the National Academy of Sciences 99 (22), 14524, 2002
Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine
V Jackson-Lewis, M Jakowec, RE Burke, S Przedborski
Neurodegeneration 4 (3), 257-269, 1995
Tardive dystonia
RE Burke, S Fahn, J Jankovic, CD Marsden, AE Lang, S Gollomp, J Ilson
Neurology 32 (12), 1335-1335, 1982
Mutant LRRK2 R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease
Y Li, W Liu, TF Oo, L Wang, Y Tang, V Jackson-Lewis, C Zhou, ...
Nature neuroscience 12 (7), 826-828, 2009
Pitx3 is required for development of substantia nigra dopaminergic neurons
I Nunes, LT Tovmasian, RM Silva, RE Burke, SP Goff
Proceedings of the National Academy of Sciences 100 (7), 4245, 2003
Axon degeneration in Parkinson's disease
RE Burke, K O'Malley
Experimental neurology 246, 72-83, 2013
6-Hydroxydopamine lesion of the rat substantia nigra: time course and morphology of cell death
BS Jeon, V Jackson-Lewis, RE Burke
Neurodegeneration 4 (2), 131-137, 1995
A critical evaluation of the Braak staging scheme for Parkinson's disease
RE Burke, WT Dauer, JPG Vonsattel
Annals of Neurology: Official Journal of the American Neurological …, 2008
Current concepts on the clinical features, aetiology and management of idiopathic cervical dystonia.
WT Dauer, RE Burke, P Greene, S Fahn
Brain 121 (4), 547, 1998
Human gene for torsion dystonia located on chromosome 9q32-q34
L Ozelius, PL Kramer, CB Moskowitz, DJ Kwiatkowski, MF Brin, ...
Neuron 2 (5), 1427-1434, 1989
Torsion dystonia
RE Burke, S Fahn, CD Marsden
Neurology 36 (2), 160-160, 1986
CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonism
RM Silva, V Ries, TF Oo, O Yarygina, V Jackson‐Lewis, EJ Ryu, PD Lu, ...
Journal of neurochemistry 95 (4), 974-986, 2005
Idiopathic dystonia among Ashkenazi Jews: evidence for autosomal dominant inheritance
SB Bressman, D De Leon, MF Brin, N Risch, RE Burke, PE Greene, ...
Annals of Neurology: Official Journal of the American Neurological …, 1989
Delayed-onset dystonia in patients with" static" encephalopathy.
RE Burke, S Fahn, AP Gold
Journal of Neurology, Neurosurgery & Psychiatry 43 (9), 789, 1980
Regulation of Presynaptic Neurotransmission by Macroautophagy
D Hernandez, CA Torres, W Setlik, C Cebrián, EV Mosharov, G Tang, ...
Neuron 74 (2), 277-284, 2012
Neuroleptic malignant syndrome caused by dopamine‐depleting drugs in a patient with Huntington disease
RE Burke, S Fahn, R Mayeux, H Weinberg, K Louis, JH Willner
Neurology 31 (8), 1022-1022, 1981
Apoptosis in neurodegenerative disorders.
L Stefanis, RE Burke, LA Greene
Current opinion in neurology 10 (4), 299, 1997
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20